Evaluation of Safety Profile of Rituximab plus Lenalidomide Protocol in Frail Elderly Relapsed/Refractory Diffuse Large B-Cell Lymphoma Patients

被引：0
|
作者：
Sevgili, Bahar [1 ]
Pashayev, Tural [2 ]
Bozer, Denis Sabriye [1 ]
Gunes, Ajda [1 ]
Karacadag, Fatma Keklik [3 ]
Saydam, Guray [1 ]
机构：
[1] Ege Univ, Dept Hematol, Fac Med, Izmir, Turkiye
[2] Liv Bona Dea Hosp, Dept Hematol, Baku, Azerbaijan
[3] Tepecik Res & Educ Hosp, Dept Hematol, Istanbul, Turkiye
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷
关键词：
relapsed or refractory; diffuse large B-cell lymphoma; partial response; case;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ABCL-152
引用
收藏
页码：S420 / S421
页数：2
相关论文
共 50 条
  • [41] BENDAMUSTINE PLUS RITUXIMAB FOR RELAPSED OR REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA: A RETROSPECTIVE STUDY
    Merchionne, F.
    Quintana, G.
    Minoia, C.
    Guarini, A.
    Galise, I.
    Quarta, G.
    Loseto, G.
    Melpignano, A.
    HAEMATOLOGICA, 2014, 99 : 696 - 697
  • [42] Subcutaneous Epcoritamab Plus Lenalidomide in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma from EPCORE NHL-5
    Mazza, Irit Avivi
    Kim, Won Seog
    Ko, Shen
    Grande, Carlos
    Lavie, David
    Chism, David
    Seliem, Mostafa
    Jeng, Edwin E.
    Joshi, Neha
    Siddani, Satya
    Assaily, Wissam
    Sacchi, Mariana
    Dinh, Minh
    Avigdor, Abraham
    BLOOD, 2023, 142
  • [43] Bendamustine combined with rituximab for patients with relapsed or refractory diffuse large B cell lymphoma
    Jeffrey L. Vacirca
    Peter. I. Acs
    Imad A. Tabbara
    Peter. J. Rosen
    Peter Lee
    Eric Lynam
    Annals of Hematology, 2014, 93 : 403 - 409
  • [44] Bendamustine combined with rituximab for patients with relapsed or refractory diffuse large B cell lymphoma
    Vacirca, Jeffrey L.
    Acs, Peter I.
    Tabbara, Imad A.
    Rosen, Peter J.
    Lee, Peter
    Lynam, Eric
    ANNALS OF HEMATOLOGY, 2014, 93 (03) : 403 - 409
  • [45] Efficacy and safety of PD-1 monoclonal antibody plus rituximab in relapsed/refractory diffuse large B cell lymphoma patients
    Qin, Yan
    He, Xiaohui
    Chen, Xinrui
    Xie, Zucheng
    Yang, Jianliang
    Yang, Sheng
    Liu, Peng
    Zhou, Shengyu
    Zhang, Changgong
    Gui, Lin
    Shi, Yuankai
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2023, 111 (03) : 356 - 364
  • [46] Trofosfamide in the treatment of elderly or frail patients with diffuse large B-cell lymphoma
    Hanno M. Witte
    Armin Riecke
    Thomas Mayer
    Tobias Bartscht
    Dirk Rades
    Hendrik Lehnert
    Hartmut Merz
    Sebastian Fetscher
    Harald Biersack
    Niklas Gebauer
    Journal of Cancer Research and Clinical Oncology, 2019, 145 : 129 - 136
  • [47] Trofosfamide in the treatment of elderly or frail patients with diffuse large B-cell lymphoma
    Witte, Hanno M.
    Riecke, Armin
    Mayer, Thomas
    Bartscht, Tobias
    Rades, Dirk
    Lehnert, Hendrik
    Merz, Hartmut
    Fetscher, Sebastian
    Biersack, Harald
    Gebauer, Niklas
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2019, 145 (01) : 129 - 136
  • [48] Zanubrutinib plus salvage chemotherapy for relapsed or refractory diffuse large B-cell lymphoma
    Yuan, Xianggui
    Li, Xian
    Huang, Yurong
    Jin, Xueli
    Liu, Hui
    Zhao, Aiqi
    Zhang, Weiping
    Qian, Wenbin
    Liang, Yun
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [49] Polatuzumab vedotin combined with bendamustine and rituximab for relapsed/refractory diffuse large B-cell lymphoma: A systematic review protocol
    Eslami, Mohammadreza
    Mehrabi, Mahdi
    Payandeh, Mehrdad
    Saba, Fakhredin
    PLOS ONE, 2024, 19 (08):
  • [50] Chidamide with PEL regimen (prednisone, etoposide, lenalidomide) for elderly or frail patients with relapsed/refractory diffuse large B-Cell lymphoma -results of a single center, retrospective cohort in China
    Wang, Yawen
    Xue, Hongwei
    Song, Wei
    Xiao, Shuxin
    Jing, Fanjing
    Dong, Tieying
    Wang, Lili
    HEMATOLOGICAL ONCOLOGY, 2022, 40 (04) : 617 - 625
12345